Efficacy and tolerability of lacosamide for secondary epileptic seizures in patients with brain tumor: A multicenter, observational retrospective study

Oncol Lett 13: 4093-4100, 2017; DOI: 10.3892/ol.2017.5988 Following the publication of this article, we have realized a couple of errors were included in the text, and would like to correct these for the record (the changed text is subsequently highlighted in bold). [...]for Fig. 2, the y-axis title should have read as: “Mean number of seizures over the last 3 months”, and the figure legend should have read as follows: “Mean number of seizures in the 3 months prior to, and during, the 3–6 month period of lacosamide treatment in patients experiencing epileptic seizures due to a brain tumor (n=26).